New York A 663: Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Status: PRINT NUMBER 663B (as of 2022-05-19)

State: New York · Session: 2021-2022 · Bill: A 663

Sponsors: ROSENTHAL D, ABINANTI, COLTON, COOK, DICKENS, GRIFFIN, JACOBSON, O'DONNELL, SEAWRIGHT, SIMON, WILLIAMS

View New York A 663 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.